The article discusses the role Biosimilars in Oncology. Topics include establishing a safe and effective means of proving biosimilarity while ensuring competition among biologic drugs; and providing substantial savings in drug development, which requires that biosimilars which meet certain criteria in the mechanism of action of the drug.